Publication:
Blood screening for influenza

Simple item page
dc.contributor.authorMichael Kai Hourfaren_US
dc.contributor.authorAnna Themannen_US
dc.contributor.authorMarkus Eickmannen_US
dc.contributor.authorPilaipan Puthavathanaen_US
dc.contributor.authorThomas Laueen_US
dc.contributor.authorErhard Seifrieden_US
dc.contributor.authorMichael Schmidten_US
dc.contributor.otherDeutsches Rotes Kreuzen_US
dc.contributor.otherUniversitat Marburgen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherQiagen GmbHen_US
dc.contributor.otherGoethe-Universitat Frankfurt am Mainen_US
dc.date.accessioned2018-08-24T02:12:51Z
dc.date.available2018-08-24T02:12:51Z
dc.date.issued2007-01-01en_US
dc.description.abstractInfluenza viruses, including highly pathogenic avian influenza virus (H5N1), could threaten blood safety. We analyzed 10,272 blood donor samples with a minipool nucleic acid amplication technique. Analytical sensitivity of the method was 804 geq/mL and 444 geq/mL for generic influenza primers and influenza (H5N1) subtype-specific primers. This study demonstrates that such screening for influenza viruses is feasible.en_US
dc.identifier.citationEmerging Infectious Diseases. Vol.13, No.7 (2007), 1081-1083en_US
dc.identifier.doi10.3201/eid1307.060861en_US
dc.identifier.issn10806059en_US
dc.identifier.issn10806040en_US
dc.identifier.other2-s2.0-34447251928en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/25076
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34447251928&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleBlood screening for influenzaen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34447251928&origin=inwarden_US

Files

Collections

Scopus 2006-2010